Posterior Reversible Encephalopathy Syndrome (PRES) - A reversible Tacrolimus induced neurotoxicity in a heart transplant recipient: A case report

Authors

  • Anantharaman R Senior Consultant Interventional Cardiologist, Kauvery Hospital, Chennai, India
  • Vivek M Frontier Lifeline Hospital, Chennai, India
  • Madhu Sankar N Frontier Lifeline Hospital, Chennai, India
  • Arulkumar A Frontier Lifeline Hospital, Chennai, India
  • Cherian KM Frontier Lifeline Hospital, Chennai, India

Abstract

Tacrolimus is widely used as an immunosuppressive drug following heart transplantation. Mild to severe forms of neurological symptoms are known to occur with use of Tacrolimus. Posterior Reversible Encephalopathy Syndrome (PRES) is one such manifestation that can present with multitude of neurological symptoms. We report a case of PRES in a heart transplant recipient receiving Tacrolimus.

Downloads

Published

2025-02-10

How to Cite

Anantharaman R, Vivek M, Madhu Sankar N, Arulkumar A, & Cherian KM. (2025). Posterior Reversible Encephalopathy Syndrome (PRES) - A reversible Tacrolimus induced neurotoxicity in a heart transplant recipient: A case report . Kauverian Medical Journal, 2(4), 21–24. Retrieved from https://kauverianjournal.com/index.php/research/article/view/150

Issue

Vol. 2 No. 4 (2025): February

Section

Articles